Login

Severn Trent CEO Liv Garfield addressing investors at the Hardman & Co Investor Forum. 00:10:00

Share On Facebook Share On Twitter

Kun-Tsung Huang is President at Shin Shin Natural Gas Co Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Mutual Fund Distributor vs. Registered Investment Advisor: Key Insights from Mr. Shyam Sekhar
00:10:00
Advantages of Large-Capacity Batteries for Underground Mining EVs
00:10:00
The Art of Storytelling with Aoifinn Devitt, CIO of the Moneta Group
00:10:00
Arizona Copper Project Poised for Production in 2025
00:00:00
Onconova Therapeutics featured on Worldwide Business - Dr. Steven Fruchtman, CEO, Onconova Therapeutics Inc
00:10:00
Inflation Stalemate and Its Impact on Federal Reserve Rate Cuts |Russell Price, Chief Economist , Ameriprise Financial Inc.
00:10:00
Narciso Berberana, CEO of Aguas Andinas, leads strategic initiatives in water management and infrastructure development.
00:10:00
Global Investments and the Future of Critical Material Markets
00:10:00
Cardio Therapeutics aims to revolutionize cardiovascular medicine through groundbreaking research and pivotal clinical trials | David Elsley, CEO, Cardiol Therapeutics Inc.
00:00:00
Christian Hoyer Millar, CEO, Oxford Biodynamics P
00:10:00
Flagstone FM's Investment Principles | DANIEL STOUS - SHAREHOLDER & LEAD WEALTH ADVISOR of Flagstone Financial Management
00:10:00
Andreas Morfiadakis on KlaraBo Sverige AB's Organic Growth and Strategies for Market Consolidation | Andreas Morfiadakis, CEO, KlaraBo Sverige AB.

© 2026 Nehu